Almonds: Digestive Health and Immune Function of Adults and Children
1 other identifier
interventional
58
1 country
1
Brief Summary
The purpose of this study is to determine whether incorporating almonds into the diets of families with young children will induce beneficial changes in gastrointestinal function, the fecal microbiota profile, and immune and inflammatory processes of the adults and children resulting in improved quality of life. The investigators anticipate finding an increase in beneficial bacteria, improved intestinal function, and decreased inflammation during the almond intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Dec 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2013
CompletedFirst Posted
Study publicly available on registry
October 31, 2013
CompletedStudy Start
First participant enrolled
December 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedResults Posted
Study results publicly available
April 25, 2016
CompletedMay 26, 2016
April 1, 2016
5 months
October 15, 2013
November 12, 2015
April 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gut Microbiota Community Composition
The mean of the change between baseline and final time points in stool lactic acid bacteria counts \[log(CFU)\] was compared for each study arm.
Baseline #1 (Week 1) to Final #1 (Week 4) of each intervention
Secondary Outcomes (3)
Inflammatory Status
Change between Baseline to Week 4
Gastrointestinal Function
Pre-baseline (Week 0) and Week 3 of each intervention
Diet Quality
Three week almond intervention vs. three week no almond intervention
Study Arms (2)
Almonds then no almonds
EXPERIMENTALAdults will consume 1.5 ounces of almonds or almond paste per day and children will consume 0.5 ounces of almonds or almond paste per day for 3 weeks.
No almonds then almonds
OTHERNo almonds will be consumed by participants for 3 weeks.
Interventions
Whole, raw almonds with skin, or whole, raw almonds with skin that have been ground into a paste.
No almonds will be consumed by participants for 3 weeks.
Eligibility Criteria
You may qualify if:
- To participate in the study, adult participants must:
- Be 18 to 40 years old.
- Have a 3 to 6 year old child that you are willing to enroll in the study.
- Live with your child for on average at least 6 days of the week.
- Be willing and able to complete the Informed Consent Form in English.
- Not be currently pregnant or planning to become pregnant in the next 5 months.
- Be willing to consume 1.5 ounces of almonds (\~43 nuts) each day for three weeks.
- Be willing to feed your child 0.5 ounces of almond paste (\~2 tablespoons) per day for three weeks.
- Be willing monitor your child's daily intake over the course of the study.
- Be willing to provide 4 blood samples, 4 stool samples, and 4 saliva samples over the course of the study.
- Be willing to assist your child in providing 4 stool samples and 4 saliva samples over the course of the study.
- Be willing and able to complete daily and weekly questionnaires for you and your child regarding general wellness, bowel function, gastrointestinal symptoms, stress and anxiety, and dietary intake.
- Must be available for 14 consecutive weeks to participate in the study.
You may not qualify if:
- To participate in the study, adult and child participants:
- Must not have any known nut or tree nut allergies.
- Must discontinue any immune-enhancing dietary supplements (e.g., prebiotics and fiber supplements, probiotics, fish oil, vitamin E \>400% of the Recommended Dietary Allowance (RDA) or \>60 mg/day, and yogurts with live, active cultures).
- Must not be currently taking any medications for constipation or diarrhea on a regular basis.
- Must not be currently taking any large doses of anti-inflammatory drugs (i.e., aspirin in doses \>600 mg/d) on a regular basis.
- Must not have received antibiotic therapy or a colonoscopy in the past two months.
- Must not be currently being treated for or have any of the following physician-diagnosed diseases or conditions: HIV/AIDS; immune modulating diseases (autoimmune disease, hepatitis, cancer); kidney disease; pancreatitis; pulmonary disease; hepatic or biliary disease; or gastrointestinal diseases/conditions such as diverticulitis, ulcerative colitis, Crohn's disease, Celiac disease, short bowel disease, ileostomy, or colostomy, but not including gastroesophageal reflux disease; or have a central venous catheter.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- Almond Board of Californiacollaborator
Study Sites (1)
University of Florida
Gainesville, Florida, 32611, United States
Related Publications (1)
Burns AM, Zitt MA, Rowe CC, Langkamp-Henken B, Mai V, Nieves C Jr, Ukhanova M, Christman MC, Dahl WJ. Diet quality improves for parents and children when almonds are incorporated into their daily diet: a randomized, crossover study. Nutr Res. 2016 Jan;36(1):80-9. doi: 10.1016/j.nutres.2015.11.004. Epub 2015 Nov 10.
PMID: 26773784DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Bobbi Langkamp- Henken
- Organization
- University of Florida
Study Officials
- PRINCIPAL INVESTIGATOR
Bobbi Langkamp-Henken, PhD, RD
University of Florida
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2013
First Posted
October 31, 2013
Study Start
December 1, 2013
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
May 26, 2016
Results First Posted
April 25, 2016
Record last verified: 2016-04